Intracin Pharma secures APVMA nod to supply veterinary medicines in Australia
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
The transaction is expected to be completed by May 15, 2025 or such other date as may be mutually agreed
The total cost of the project is estimated at Rs 30 crore
In animal health, the products will be mainly targeting mastitis and production disorders, gastrointestinal tract diseases, reproductive disorders, ectoparasites, and skin injuries
Shashwat Goenka takes over as Vice President of industry body
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
Subscribe To Our Newsletter & Stay Updated